PPC
EXAS

Park Place Capital’s Exact Sciences EXAS Stock Holding History

Park Place Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-461
Closed -$31.4K – 923
2023
Q3 		$31.4K Buy
461
+91
+25% +$7.72K 0.01% 557
2023
Q2 		$34.7K Sell
370
-6
-2% -$468 0.01% 553
2023
Q1 		$25.5K Buy
376
+246
+189% +$15.8K 0.01% 599
2022
Q4 		$6K Buy
+130
New +$5.31K ﹤0.01% 831

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Park Place Capital's EXAS Position: Q4 2023 in Review

Park Place Capital sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 461 shares — an estimated $31.4K sold.

Park Place Capital first reported a position in EXAS in Q4 2022 and held it in 4 quarters. The position peaked at $34.7K in Q2 2023. 647 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Park Place Capital reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Park Place Capital sold 461 Exact Sciences shares in Q4 2023, an estimated $31.4K.
  • Park Place Capital first reported a position in Exact Sciences in Q4 2022 and held it in 4 quarters.
  • Park Place Capital's Exact Sciences position peaked at $34.7K in Q2 2023.
  • 647 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Park Place Capital's 13F filing for Q4 2023, filed 24 Jan 2024.